Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction

Martin S Maron1, Iacopo Olivotto, Andrey G Zenovich

  • 1Hypertrophic Cardiomyopathy Center, Division of Cardiology, Tufts-New England Medical Center, Boston, MA 02111, USA. mmaron@tufts-nemc.org

Circulation
|November 8, 2006
PubMed

Insights

Hypertrophic cardiomyopathy (HCM) is often an obstructive disease, with 70% of patients showing left ventricular (LV) outflow obstruction. Exercise echocardiography is crucial for identifying obstruction and guiding treatment in HCM patients.

Area of Science:

  • Cardiology
  • Cardiovascular Medicine
  • Clinical Echocardiography

Background:

  • Hypertrophic cardiomyopathy (HCM) is traditionally viewed as nonobstructive based on resting gradients.
  • Previous assessments underestimated the prevalence of left ventricular (LV) outflow tract obstruction.

Purpose of the Study:

  • To prospectively determine the prevalence and clinical significance of LV outflow tract obstruction in a large HCM cohort.
  • To evaluate obstruction at rest and during physiological stress (exercise).

Main Methods:

  • Prospective analysis of 320 HCM patients.
  • Measurement of LV outflow gradients at rest, during Valsalva maneuver, and with exercise echocardiography.

Main Results:

  • 70% of patients (225/320) exhibited LV outflow obstruction at rest and/or with exercise.
  • Exercise revealed obstruction in 106 patients (53%) previously showing minimal resting gradients.
  • Valsalva maneuver underestimated exercise-induced obstruction.

Conclusions:

  • HCM is predominantly an obstructive disease, with obstruction evident in most evaluated patients.
  • Exercise echocardiography is vital for identifying obstruction, often linked to heart failure symptoms.
  • Routine assessment of subaortic gradients during exercise is recommended for HCM patients without resting obstruction.
Abstract

Related Concept Videos

Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...